We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Seacoast Banking Corp of Florida
SBCF
$3.47B
| $735K | ﹤0.01% |
+24,330
| New | +$812K |
|
|
TBI
802
Trueblue
TBI
$303M
| $734K | ﹤0.01% |
38,445
-290
| -0.7% | -$5.87K |
|
|
SI
803
DELISTED
Silvergate Capital Corporation
SI
| $733K | ﹤0.01% |
9,730
+3,989
| +69% | +$340K |
|
804
MediaAlpha
MAX
$798M
| $732K | ﹤0.01% |
83,635
+23,969
| +40% | +$233K |
|
805
Heron Therapeutics
HRTX
$61.4M
| $730K | ﹤0.01% |
+173,053
| New | +$677K |
|
806
Lennar Class B
LEN.B
$20.6B
| $729K | ﹤0.01% |
12,879
-58,169
| -82% | -$3.54M |
|
807
Highwoods Properties
HIW
$3.51B
| $727K | ﹤0.01% |
26,975
-13,015
| -33% | -$420K |
|
808
Intuitive Surgical
ISRG
$142B
| $727K | ﹤0.01% |
3,877
+1,945
| +101% | +$418K |
|
809
Mercantile Bank Corp
MBWM
$1.06B
| $726K | ﹤0.01% |
24,451
+9,975
| +69% | +$333K |
|
810
Movado Group
MOV
$806M
| $723K | ﹤0.01% |
25,659
| – | – |
|
|
ZEUS
811
DELISTED
Olympic Steel
ZEUS
| $722K | ﹤0.01% |
31,641
+23,377
| +283% | +$630K |
|
|
LTHM
812
DELISTED
Livent Corporation
LTHM
| $721K | ﹤0.01% |
23,520
+8,582
| +57% | +$241K |
|
813
RPC Inc
RES
$1.39B
| $714K | ﹤0.01% |
+103,050
| New | +$747K |
|
|
CTRA
814
DELISTED
Coterra Energy
CTRA
| $711K | ﹤0.01% |
27,233
-690,585
| -96% | -$19.8M |
|
815
Great Southern Bancorp
GSBC
$882M
| $709K | ﹤0.01% |
+12,415
| New | +$749K |
|
816
Digital Realty Trust
DLR
$73.3B
| $707K | ﹤0.01% |
7,128
+3,029
| +74% | +$371K |
|
|
PGTI
817
DELISTED
PGT, Inc.
PGTI
| $706K | ﹤0.01% |
+33,678
| New | +$692K |
|
818
Century Communities
CCS
$2.02B
| $705K | ﹤0.01% |
16,473
-21,943
| -57% | -$1.06M |
|
|
CHX
819
DELISTED
ChampionX
CHX
| $705K | ﹤0.01% |
36,000
-5,882
| -14% | -$121K |
|
820
Financial Institutions
FISI
$825M
| $704K | ﹤0.01% |
29,238
| – | – |
|
821
Eagle Bancorp
EGBN
$879M
| $698K | ﹤0.01% |
15,565
-900
| -5% | -$43K |
|
822
1st Source
SRCE
$2.14B
| $697K | ﹤0.01% |
+15,057
| New | +$715K |
|
823
Super Micro Computer
SMCI
$25.6B
| $696K | ﹤0.01% |
+126,430
| New | +$720K |
|
824
Monarch Casino & Resort
MCRI
$2.17B
| $691K | ﹤0.01% |
12,316
-9,282
| -43% | -$569K |
|
825
PubMatic
PUBM
$790M
| $691K | ﹤0.01% |
+41,568
| New | +$751K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.